MedTrace Logo

Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19

NCT04345406 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-04-14

No results posted yet for this study

Summary

ACEIs as treatment for COVID19

Conditions

Interventions

DRUG

ACEIs

Captopril or enalapril

DRUG

Conventional treatment

alexoquine

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Sherief Abd-Elsalam, ass. prof. · Tanta University Faculty of medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2029-12-01
Completion
2029-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04345406 on ClinicalTrials.gov